Global Medications for Alcohol Use Disorder (AUD) Market Growth (Status and Outlook) 2026-2032
The global Medications for Alcohol Use Disorder (AUD) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Alcohol use disorder (AUD), is a chronic condition characterized by an inability to control alcohol consumption despite negative consequences. It involves a physical and psychological dependence on alcohol, where individuals may experience cravings, withdrawal symptoms, and a persistent desire to drink. Medications for Alcohol Use Disorder (AUD) are an important component of treatment, helping individuals manage cravings, reduce alcohol consumption, and maintain sobriety. Currently, commonly used drugs include naltrexone, acamprosate, etc.
United States market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Medications for Alcohol Use Disorder (AUD) players cover Alkermes, Merck KGaA, Lundbeck, Alvogen, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Medications for Alcohol Use Disorder (AUD) Industry Forecast? looks at past sales and reviews total world Medications for Alcohol Use Disorder (AUD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Medications for Alcohol Use Disorder (AUD) sales for 2026 through 2032. With Medications for Alcohol Use Disorder (AUD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medications for Alcohol Use Disorder (AUD) industry.
This Insight Report provides a comprehensive analysis of the global Medications for Alcohol Use Disorder (AUD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medications for Alcohol Use Disorder (AUD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Medications for Alcohol Use Disorder (AUD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medications for Alcohol Use Disorder (AUD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medications for Alcohol Use Disorder (AUD).
This report presents a comprehensive overview, market shares, and growth opportunities of Medications for Alcohol Use Disorder (AUD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Alcohol use disorder (AUD), is a chronic condition characterized by an inability to control alcohol consumption despite negative consequences. It involves a physical and psychological dependence on alcohol, where individuals may experience cravings, withdrawal symptoms, and a persistent desire to drink. Medications for Alcohol Use Disorder (AUD) are an important component of treatment, helping individuals manage cravings, reduce alcohol consumption, and maintain sobriety. Currently, commonly used drugs include naltrexone, acamprosate, etc.
United States market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Medications for Alcohol Use Disorder (AUD) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Medications for Alcohol Use Disorder (AUD) players cover Alkermes, Merck KGaA, Lundbeck, Alvogen, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Medications for Alcohol Use Disorder (AUD) Industry Forecast? looks at past sales and reviews total world Medications for Alcohol Use Disorder (AUD) sales in 2025, providing a comprehensive analysis by region and market sector of projected Medications for Alcohol Use Disorder (AUD) sales for 2026 through 2032. With Medications for Alcohol Use Disorder (AUD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medications for Alcohol Use Disorder (AUD) industry.
This Insight Report provides a comprehensive analysis of the global Medications for Alcohol Use Disorder (AUD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medications for Alcohol Use Disorder (AUD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Medications for Alcohol Use Disorder (AUD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medications for Alcohol Use Disorder (AUD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medications for Alcohol Use Disorder (AUD).
This report presents a comprehensive overview, market shares, and growth opportunities of Medications for Alcohol Use Disorder (AUD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Naltrexone
- Acamprosate
- Disulfiram
- Other
- Hospital
- Rehabilitation Institutions
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alkermes
- Merck KGaA
- Lundbeck
- Alvogen
- Mylan
- Teva
- Sun Pharmaceutical Industries
- Zydus Pharmaceuticals
- Taj Pharmaceuticals
- TAGI Pharma Inc.
- Beijing Wellso Pharmaceutical Co
- Glenmark Pharmaceuticals
- Rusan Pharma Ltd
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
2.1.2 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Medications for Alcohol Use Disorder (AUD) by Country/Region (2021, 2025 & 2032)
2.2 Medications for Alcohol Use Disorder (AUD) Segment by Type
2.2.1 Naltrexone
2.2.2 Acamprosate
2.2.3 Disulfiram
2.2.4 Other
2.2.5 Medications for Alcohol Use Disorder (AUD) Market Size by Type
2.2.5.1 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
2.3 Medications for Alcohol Use Disorder (AUD) Segment by Application
2.3.1 Hospital
2.3.2 Rehabilitation Institutions
2.3.3 Others
2.3.4 Medications for Alcohol Use Disorder (AUD) Market Size by Application
2.3.4.1 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
3 MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) MARKET SIZE BY PLAYER
3.1 Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Player
3.1.1 Global Medications for Alcohol Use Disorder (AUD) Revenue by Player (2021-2026)
3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player (2021-2026)
3.2 Global Medications for Alcohol Use Disorder (AUD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) BY REGION
4.1 Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
4.2 Global Medications for Alcohol Use Disorder (AUD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.4 APAC Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.5 Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.6 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
5.2 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
5.3 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
6.2 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
6.3 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) by Region (2021-2026)
8.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
8.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) MARKET FORECAST
10.1 Global Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.1.1 Global Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.1.2 Americas Medications for Alcohol Use Disorder (AUD) Forecast
10.1.3 APAC Medications for Alcohol Use Disorder (AUD) Forecast
10.1.4 Europe Medications for Alcohol Use Disorder (AUD) Forecast
10.1.5 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Forecast
10.2 Americas Medications for Alcohol Use Disorder (AUD) Forecast by Country (2027-2032)
10.2.1 United States Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.2 Canada Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.3 Mexico Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.4 Brazil Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3 APAC Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.3.1 China Medications for Alcohol Use Disorder (AUD) Market Forecast
10.3.2 Japan Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.3 Korea Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.4 Southeast Asia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.5 India Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.6 Australia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4 Europe Medications for Alcohol Use Disorder (AUD) Forecast by Country (2027-2032)
10.4.1 Germany Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.2 France Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.3 UK Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.4 Italy Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.5 Russia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.5.1 Egypt Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.2 South Africa Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.3 Israel Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.4 Turkey Market Medications for Alcohol Use Disorder (AUD) Forecast
10.6 Global Medications for Alcohol Use Disorder (AUD) Forecast by Type (2027-2032)
10.7 Global Medications for Alcohol Use Disorder (AUD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Medications for Alcohol Use Disorder (AUD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Medications for Alcohol Use Disorder (AUD) Product Offered
11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Offered
11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Lundbeck
11.3.1 Lundbeck Company Information
11.3.2 Lundbeck Medications for Alcohol Use Disorder (AUD) Product Offered
11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lundbeck Main Business Overview
11.3.5 Lundbeck Latest Developments
11.4 Alvogen
11.4.1 Alvogen Company Information
11.4.2 Alvogen Medications for Alcohol Use Disorder (AUD) Product Offered
11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Alvogen Main Business Overview
11.4.5 Alvogen Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Medications for Alcohol Use Disorder (AUD) Product Offered
11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Medications for Alcohol Use Disorder (AUD) Product Offered
11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Information
11.7.2 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Offered
11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sun Pharmaceutical Industries Main Business Overview
11.7.5 Sun Pharmaceutical Industries Latest Developments
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Information
11.8.2 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Zydus Pharmaceuticals Main Business Overview
11.8.5 Zydus Pharmaceuticals Latest Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Taj Pharmaceuticals Main Business Overview
11.9.5 Taj Pharmaceuticals Latest Developments
11.10 TAGI Pharma Inc.
11.10.1 TAGI Pharma Inc. Company Information
11.10.2 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Offered
11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 TAGI Pharma Inc. Main Business Overview
11.10.5 TAGI Pharma Inc. Latest Developments
11.11 Beijing Wellso Pharmaceutical Co
11.11.1 Beijing Wellso Pharmaceutical Co Company Information
11.11.2 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Offered
11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Wellso Pharmaceutical Co Main Business Overview
11.11.5 Beijing Wellso Pharmaceutical Co Latest Developments
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Information
11.12.2 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Glenmark Pharmaceuticals Main Business Overview
11.12.5 Glenmark Pharmaceuticals Latest Developments
11.13 Rusan Pharma Ltd
11.13.1 Rusan Pharma Ltd Company Information
11.13.2 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Offered
11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Rusan Pharma Ltd Main Business Overview
11.13.5 Rusan Pharma Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medications for Alcohol Use Disorder (AUD) Market Size (2021-2032)
2.1.2 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Medications for Alcohol Use Disorder (AUD) by Country/Region (2021, 2025 & 2032)
2.2 Medications for Alcohol Use Disorder (AUD) Segment by Type
2.2.1 Naltrexone
2.2.2 Acamprosate
2.2.3 Disulfiram
2.2.4 Other
2.2.5 Medications for Alcohol Use Disorder (AUD) Market Size by Type
2.2.5.1 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
2.3 Medications for Alcohol Use Disorder (AUD) Segment by Application
2.3.1 Hospital
2.3.2 Rehabilitation Institutions
2.3.3 Others
2.3.4 Medications for Alcohol Use Disorder (AUD) Market Size by Application
2.3.4.1 Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
3 MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) MARKET SIZE BY PLAYER
3.1 Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Player
3.1.1 Global Medications for Alcohol Use Disorder (AUD) Revenue by Player (2021-2026)
3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player (2021-2026)
3.2 Global Medications for Alcohol Use Disorder (AUD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) BY REGION
4.1 Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
4.2 Global Medications for Alcohol Use Disorder (AUD) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.4 APAC Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.5 Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
4.6 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
5.2 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
5.3 Americas Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026)
6.2 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
6.3 APAC Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026)
7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) by Region (2021-2026)
8.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026)
8.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MEDICATIONS FOR ALCOHOL USE DISORDER (AUD) MARKET FORECAST
10.1 Global Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.1.1 Global Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.1.2 Americas Medications for Alcohol Use Disorder (AUD) Forecast
10.1.3 APAC Medications for Alcohol Use Disorder (AUD) Forecast
10.1.4 Europe Medications for Alcohol Use Disorder (AUD) Forecast
10.1.5 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Forecast
10.2 Americas Medications for Alcohol Use Disorder (AUD) Forecast by Country (2027-2032)
10.2.1 United States Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.2 Canada Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.3 Mexico Market Medications for Alcohol Use Disorder (AUD) Forecast
10.2.4 Brazil Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3 APAC Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.3.1 China Medications for Alcohol Use Disorder (AUD) Market Forecast
10.3.2 Japan Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.3 Korea Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.4 Southeast Asia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.5 India Market Medications for Alcohol Use Disorder (AUD) Forecast
10.3.6 Australia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4 Europe Medications for Alcohol Use Disorder (AUD) Forecast by Country (2027-2032)
10.4.1 Germany Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.2 France Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.3 UK Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.4 Italy Market Medications for Alcohol Use Disorder (AUD) Forecast
10.4.5 Russia Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Forecast by Region (2027-2032)
10.5.1 Egypt Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.2 South Africa Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.3 Israel Market Medications for Alcohol Use Disorder (AUD) Forecast
10.5.4 Turkey Market Medications for Alcohol Use Disorder (AUD) Forecast
10.6 Global Medications for Alcohol Use Disorder (AUD) Forecast by Type (2027-2032)
10.7 Global Medications for Alcohol Use Disorder (AUD) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Medications for Alcohol Use Disorder (AUD) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Medications for Alcohol Use Disorder (AUD) Product Offered
11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Offered
11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Lundbeck
11.3.1 Lundbeck Company Information
11.3.2 Lundbeck Medications for Alcohol Use Disorder (AUD) Product Offered
11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Lundbeck Main Business Overview
11.3.5 Lundbeck Latest Developments
11.4 Alvogen
11.4.1 Alvogen Company Information
11.4.2 Alvogen Medications for Alcohol Use Disorder (AUD) Product Offered
11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Alvogen Main Business Overview
11.4.5 Alvogen Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Medications for Alcohol Use Disorder (AUD) Product Offered
11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Medications for Alcohol Use Disorder (AUD) Product Offered
11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Teva Main Business Overview
11.6.5 Teva Latest Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Information
11.7.2 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Offered
11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Sun Pharmaceutical Industries Main Business Overview
11.7.5 Sun Pharmaceutical Industries Latest Developments
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Information
11.8.2 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Zydus Pharmaceuticals Main Business Overview
11.8.5 Zydus Pharmaceuticals Latest Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Taj Pharmaceuticals Main Business Overview
11.9.5 Taj Pharmaceuticals Latest Developments
11.10 TAGI Pharma Inc.
11.10.1 TAGI Pharma Inc. Company Information
11.10.2 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Offered
11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 TAGI Pharma Inc. Main Business Overview
11.10.5 TAGI Pharma Inc. Latest Developments
11.11 Beijing Wellso Pharmaceutical Co
11.11.1 Beijing Wellso Pharmaceutical Co Company Information
11.11.2 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Offered
11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Beijing Wellso Pharmaceutical Co Main Business Overview
11.11.5 Beijing Wellso Pharmaceutical Co Latest Developments
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Information
11.12.2 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Glenmark Pharmaceuticals Main Business Overview
11.12.5 Glenmark Pharmaceuticals Latest Developments
11.13 Rusan Pharma Ltd
11.13.1 Rusan Pharma Ltd Company Information
11.13.2 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Offered
11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Rusan Pharma Ltd Main Business Overview
11.13.5 Rusan Pharma Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Medications for Alcohol Use Disorder (AUD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Naltrexone
Table 4. Major Players of Acamprosate
Table 5. Major Players of Disulfiram
Table 6. Major Players of Other
Table 7. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Table 10. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Table 13. Global Medications for Alcohol Use Disorder (AUD) Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player (2021-2026)
Table 15. Medications for Alcohol Use Disorder (AUD) Key Players Head office and Products Offered
Table 16. Medications for Alcohol Use Disorder (AUD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Table 21. Global Medications for Alcohol Use Disorder (AUD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country (2021-2026)
Table 25. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Table 27. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Table 29. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Table 31. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country (2021-2026)
Table 35. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Medications for Alcohol Use Disorder (AUD)
Table 41. Key Market Challenges & Risks of Medications for Alcohol Use Disorder (AUD)
Table 42. Key Industry Trends of Medications for Alcohol Use Disorder (AUD)
Table 43. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Alkermes Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 48. Alkermes Medications for Alcohol Use Disorder (AUD) Product Offered
Table 49. Alkermes Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Alkermes Main Business
Table 51. Alkermes Latest Developments
Table 52. Merck KGaA Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 53. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Offered
Table 54. Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Merck KGaA Main Business
Table 56. Merck KGaA Latest Developments
Table 57. Lundbeck Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 58. Lundbeck Medications for Alcohol Use Disorder (AUD) Product Offered
Table 59. Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Lundbeck Main Business
Table 61. Lundbeck Latest Developments
Table 62. Alvogen Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 63. Alvogen Medications for Alcohol Use Disorder (AUD) Product Offered
Table 64. Alvogen Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Alvogen Main Business
Table 66. Alvogen Latest Developments
Table 67. Mylan Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 68. Mylan Medications for Alcohol Use Disorder (AUD) Product Offered
Table 69. Mylan Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mylan Main Business
Table 71. Mylan Latest Developments
Table 72. Teva Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 73. Teva Medications for Alcohol Use Disorder (AUD) Product Offered
Table 74. Teva Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Teva Main Business
Table 76. Teva Latest Developments
Table 77. Sun Pharmaceutical Industries Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 78. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Offered
Table 79. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Sun Pharmaceutical Industries Main Business
Table 81. Sun Pharmaceutical Industries Latest Developments
Table 82. Zydus Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 83. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 84. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Zydus Pharmaceuticals Main Business
Table 86. Zydus Pharmaceuticals Latest Developments
Table 87. Taj Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 88. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 89. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Taj Pharmaceuticals Main Business
Table 91. Taj Pharmaceuticals Latest Developments
Table 92. TAGI Pharma Inc. Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 93. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Offered
Table 94. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. TAGI Pharma Inc. Main Business
Table 96. TAGI Pharma Inc. Latest Developments
Table 97. Beijing Wellso Pharmaceutical Co Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 98. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Offered
Table 99. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Beijing Wellso Pharmaceutical Co Main Business
Table 101. Beijing Wellso Pharmaceutical Co Latest Developments
Table 102. Glenmark Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 103. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 104. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Glenmark Pharmaceuticals Main Business
Table 106. Glenmark Pharmaceuticals Latest Developments
Table 107. Rusan Pharma Ltd Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 108. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Offered
Table 109. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Rusan Pharma Ltd Main Business
Table 111. Rusan Pharma Ltd Latest Developments
Table 1. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Medications for Alcohol Use Disorder (AUD) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Naltrexone
Table 4. Major Players of Acamprosate
Table 5. Major Players of Disulfiram
Table 6. Major Players of Other
Table 7. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Table 10. Medications for Alcohol Use Disorder (AUD) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Table 13. Global Medications for Alcohol Use Disorder (AUD) Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player (2021-2026)
Table 15. Medications for Alcohol Use Disorder (AUD) Key Players Head office and Products Offered
Table 16. Medications for Alcohol Use Disorder (AUD) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Table 21. Global Medications for Alcohol Use Disorder (AUD) Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country (2021-2026)
Table 25. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Table 27. Americas Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Table 29. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Table 31. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country (2021-2026)
Table 35. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Medications for Alcohol Use Disorder (AUD)
Table 41. Key Market Challenges & Risks of Medications for Alcohol Use Disorder (AUD)
Table 42. Key Industry Trends of Medications for Alcohol Use Disorder (AUD)
Table 43. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Medications for Alcohol Use Disorder (AUD) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Alkermes Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 48. Alkermes Medications for Alcohol Use Disorder (AUD) Product Offered
Table 49. Alkermes Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Alkermes Main Business
Table 51. Alkermes Latest Developments
Table 52. Merck KGaA Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 53. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product Offered
Table 54. Merck KGaA Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Merck KGaA Main Business
Table 56. Merck KGaA Latest Developments
Table 57. Lundbeck Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 58. Lundbeck Medications for Alcohol Use Disorder (AUD) Product Offered
Table 59. Lundbeck Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Lundbeck Main Business
Table 61. Lundbeck Latest Developments
Table 62. Alvogen Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 63. Alvogen Medications for Alcohol Use Disorder (AUD) Product Offered
Table 64. Alvogen Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Alvogen Main Business
Table 66. Alvogen Latest Developments
Table 67. Mylan Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 68. Mylan Medications for Alcohol Use Disorder (AUD) Product Offered
Table 69. Mylan Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Mylan Main Business
Table 71. Mylan Latest Developments
Table 72. Teva Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 73. Teva Medications for Alcohol Use Disorder (AUD) Product Offered
Table 74. Teva Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Teva Main Business
Table 76. Teva Latest Developments
Table 77. Sun Pharmaceutical Industries Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 78. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product Offered
Table 79. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Sun Pharmaceutical Industries Main Business
Table 81. Sun Pharmaceutical Industries Latest Developments
Table 82. Zydus Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 83. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 84. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Zydus Pharmaceuticals Main Business
Table 86. Zydus Pharmaceuticals Latest Developments
Table 87. Taj Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 88. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 89. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Taj Pharmaceuticals Main Business
Table 91. Taj Pharmaceuticals Latest Developments
Table 92. TAGI Pharma Inc. Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 93. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product Offered
Table 94. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. TAGI Pharma Inc. Main Business
Table 96. TAGI Pharma Inc. Latest Developments
Table 97. Beijing Wellso Pharmaceutical Co Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 98. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product Offered
Table 99. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Beijing Wellso Pharmaceutical Co Main Business
Table 101. Beijing Wellso Pharmaceutical Co Latest Developments
Table 102. Glenmark Pharmaceuticals Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 103. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product Offered
Table 104. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Glenmark Pharmaceuticals Main Business
Table 106. Glenmark Pharmaceuticals Latest Developments
Table 107. Rusan Pharma Ltd Details, Company Type, Medications for Alcohol Use Disorder (AUD) Area Served and Its Competitors
Table 108. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product Offered
Table 109. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Rusan Pharma Ltd Main Business
Table 111. Rusan Pharma Ltd Latest Developments
LIST OF FIGURES
Figure 1. Medications for Alcohol Use Disorder (AUD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Medications for Alcohol Use Disorder (AUD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Medications for Alcohol Use Disorder (AUD) Sales Market Share by Country/Region (2025)
Figure 8. Medications for Alcohol Use Disorder (AUD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type in 2025
Figure 10. Medications for Alcohol Use Disorder (AUD) in Hospital
Figure 11. Global Medications for Alcohol Use Disorder (AUD) Market: Hospital (2021-2026) & ($ millions)
Figure 12. Medications for Alcohol Use Disorder (AUD) in Rehabilitation Institutions
Figure 13. Global Medications for Alcohol Use Disorder (AUD) Market: Rehabilitation Institutions (2021-2026) & ($ millions)
Figure 14. Medications for Alcohol Use Disorder (AUD) in Others
Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market: Others (2021-2026) & ($ millions)
Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application in 2025
Figure 17. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player in 2025
Figure 18. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 20. APAC Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 21. Europe Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 23. Americas Medications for Alcohol Use Disorder (AUD) Value Market Share by Country in 2025
Figure 24. United States Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region in 2025
Figure 29. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 31. China Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country in 2025
Figure 38. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 54. APAC Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 55. Europe Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 57. United States Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 58. Canada Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 61. China Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 62. Japan Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 63. Korea Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 65. India Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 66. Australia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 67. Germany Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 68. France Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 69. UK Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 70. Italy Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 71. Russia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 74. Israel Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 76. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 1. Medications for Alcohol Use Disorder (AUD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Medications for Alcohol Use Disorder (AUD) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Medications for Alcohol Use Disorder (AUD) Sales Market Share by Country/Region (2025)
Figure 8. Medications for Alcohol Use Disorder (AUD) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type in 2025
Figure 10. Medications for Alcohol Use Disorder (AUD) in Hospital
Figure 11. Global Medications for Alcohol Use Disorder (AUD) Market: Hospital (2021-2026) & ($ millions)
Figure 12. Medications for Alcohol Use Disorder (AUD) in Rehabilitation Institutions
Figure 13. Global Medications for Alcohol Use Disorder (AUD) Market: Rehabilitation Institutions (2021-2026) & ($ millions)
Figure 14. Medications for Alcohol Use Disorder (AUD) in Others
Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market: Others (2021-2026) & ($ millions)
Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application in 2025
Figure 17. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Player in 2025
Figure 18. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Figure 19. Americas Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 20. APAC Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 21. Europe Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size 2021-2026 ($ millions)
Figure 23. Americas Medications for Alcohol Use Disorder (AUD) Value Market Share by Country in 2025
Figure 24. United States Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region in 2025
Figure 29. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 30. APAC Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 31. China Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 35. India Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Country in 2025
Figure 38. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 39. Europe Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 40. Germany Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 41. France Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Medications for Alcohol Use Disorder (AUD) Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 54. APAC Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 55. Europe Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 57. United States Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 58. Canada Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 59. Mexico Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 60. Brazil Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 61. China Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 62. Japan Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 63. Korea Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 65. India Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 66. Australia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 67. Germany Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 68. France Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 69. UK Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 70. Italy Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 71. Russia Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 72. Egypt Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 73. South Africa Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 74. Israel Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 75. Turkey Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
Figure 76. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Medications for Alcohol Use Disorder (AUD) Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Medications for Alcohol Use Disorder (AUD) Market Size 2027-2032 ($ millions)
